BR0108471A - Objeto pré-formado para liberar um agente ativo a um paciente, e, processos de formação de um objeto pré-formado para liberar um agente e de liberação de um agente ativo a um paciente - Google Patents
Objeto pré-formado para liberar um agente ativo a um paciente, e, processos de formação de um objeto pré-formado para liberar um agente e de liberação de um agente ativo a um pacienteInfo
- Publication number
- BR0108471A BR0108471A BR0108471-2A BR0108471A BR0108471A BR 0108471 A BR0108471 A BR 0108471A BR 0108471 A BR0108471 A BR 0108471A BR 0108471 A BR0108471 A BR 0108471A
- Authority
- BR
- Brazil
- Prior art keywords
- release
- patient
- active agent
- agent
- preformed object
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"OBJETO PRé-FORMADO PARA LIBERAR UM AGENTE ATIVO A UM PACIENTE, E, PROCESSOS DE FORMAçãO DE UM OBJETO PRé-FORMADO PARA LIBERAR UM AGENTE E DE LIBERAçãO DE UM AGENTE ATIVO A UM PACIENTE". Um objeto pré-formado para liberar um agente ativo a um paciente, o objeto pré-formado incluindo proteina reticulada, e processos de sua produção e uso.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18355600P | 2000-02-17 | 2000-02-17 | |
PCT/US2001/005020 WO2001060335A2 (en) | 2000-02-17 | 2001-02-16 | Delivery systems using preformed biodegradable polymer compositions and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0108471A true BR0108471A (pt) | 2002-10-29 |
Family
ID=22673311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0108471-2A BR0108471A (pt) | 2000-02-17 | 2001-02-16 | Objeto pré-formado para liberar um agente ativo a um paciente, e, processos de formação de um objeto pré-formado para liberar um agente e de liberação de um agente ativo a um paciente |
Country Status (11)
Country | Link |
---|---|
US (1) | US6576263B2 (pt) |
EP (1) | EP1257257B1 (pt) |
JP (2) | JP5154726B2 (pt) |
KR (1) | KR20020081687A (pt) |
CN (1) | CN1211076C (pt) |
AU (2) | AU3838401A (pt) |
BR (1) | BR0108471A (pt) |
CA (1) | CA2398668C (pt) |
ES (1) | ES2706000T3 (pt) |
MX (1) | MXPA02007938A (pt) |
WO (1) | WO2001060335A2 (pt) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020081687A (ko) * | 2000-02-17 | 2002-10-30 | 쓰리엠 이노베이티브 프로퍼티즈 캄파니 | 예비성형된 생분해성 중합체 조성물을 사용하는 전달시스템과 방법들 |
GB0111420D0 (en) * | 2001-05-10 | 2001-07-04 | Biovector Solutions Ltd | Soluble polymer systems for drug delivery |
US7056535B2 (en) * | 2001-12-20 | 2006-06-06 | Kimberly-Clark Worldwide, Inc. | Triggered release from proteinoid microspheres |
US20030138975A1 (en) * | 2001-12-20 | 2003-07-24 | Kimberly-Clark Worldwide, Inc. | Diagnostic signal amplification with proteinoid microspheres |
US20040127563A1 (en) * | 2002-03-22 | 2004-07-01 | Deslauriers Richard J. | Methods of performing medical procedures which promote bone growth, compositions which promote bone growth, and methods of making such compositions |
US7964207B2 (en) * | 2002-03-22 | 2011-06-21 | Doctor's Research Group, Inc. | Methods of performing medical procedures that promote bone growth, method of making compositions that promote bone growth, and apparatus for use in such methods |
CA2479920A1 (en) * | 2002-03-29 | 2003-10-09 | The Regents Of The University Of California | Microgel particles for the delivery of bioactive materials |
US20040219214A1 (en) * | 2002-12-30 | 2004-11-04 | Angiotech International Ag | Tissue reactive compounds and compositions and uses thereof |
JP2006516548A (ja) | 2002-12-30 | 2006-07-06 | アンジオテック インターナショナル アクツィエン ゲゼルシャフト | 迅速ゲル化ポリマー組成物からの薬物送達法 |
CA2529528A1 (en) | 2003-06-20 | 2004-12-29 | Ronald Aung-Din | Topical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions |
CA2536041A1 (en) * | 2003-11-10 | 2005-05-26 | Angiotech International Ag | Medical implants and fibrosis-inducing agents |
CN101052684B (zh) * | 2004-07-09 | 2014-02-12 | 克利夫兰临床基金会 | 羟基苯交联大分子网络及其应用 |
WO2006078320A2 (en) | 2004-08-04 | 2006-07-27 | Brookwood Pharmaceuticals, Inc. | Methods for manufacturing delivery devices and devices thereof |
US20070231362A1 (en) | 2006-04-04 | 2007-10-04 | 3M Innovative Properties Company | Schistose microfibrillated article for cell growth |
US20070238167A1 (en) | 2006-04-04 | 2007-10-11 | 3M Innovative Properties Company | Flat microfibers as matrices for cell growth |
US8685421B2 (en) | 2006-07-07 | 2014-04-01 | Surmodics, Inc. | Beaded wound spacer device |
US9114127B2 (en) * | 2007-05-15 | 2015-08-25 | Richard C. K. Yen | Biologic devices for hemostasis |
DE102007034580B4 (de) | 2007-07-13 | 2012-11-08 | NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen | Biomaterial basierend auf einem hydrophilen polymeren Träger |
EP2222281B1 (en) | 2007-12-20 | 2018-12-05 | Evonik Corporation | Process for preparing microparticles having a low residual solvent volume |
US20090202609A1 (en) * | 2008-01-06 | 2009-08-13 | Keough Steven J | Medical device with coating composition |
DE102008008071A1 (de) | 2008-01-28 | 2009-08-06 | NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen | Injizierbare biokompatible Zusammensetzung |
WO2010005507A1 (en) | 2008-06-30 | 2010-01-14 | Afgin Pharma, Llc | Topical regional neuro-affective therapy |
DE102009051575A1 (de) * | 2009-10-26 | 2011-04-28 | NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen | Verwendung von biokompatiblen Zusammensetzungen und hieraus polymerisierten Materialien zur Inhibierung der Angiogenese |
US10285936B2 (en) | 2010-05-31 | 2019-05-14 | Laboratorios Farmacéuticos Rovi, S.A. | Injectable composition with aromatase inhibitor |
US10335366B2 (en) | 2010-05-31 | 2019-07-02 | Laboratorios Farmacéuticos Rovi, S.A. | Risperidone or paliperidone implant formulation |
US10350159B2 (en) | 2010-05-31 | 2019-07-16 | Laboratories Farmacéuticos Rovi, S.A. | Paliperidone implant formulation |
JP6298468B2 (ja) | 2012-10-16 | 2018-03-20 | サーモディクス,インコーポレイテッド | 創傷充填デバイスおよび方法 |
US10201457B2 (en) | 2014-08-01 | 2019-02-12 | Surmodics, Inc. | Wound packing device with nanotextured surface |
DE102017207049A1 (de) * | 2017-04-26 | 2018-10-31 | Tetec Tissue Engineering Technologies Ag | Zellfreie Kombination, hydrogelartiges Material oder Hydrogel sowie Verwendungen davon |
AU2020308865A1 (en) | 2019-06-26 | 2022-02-17 | Davol Inc. | Reactive dry powdered hemostatic materials comprising a nucleophile and a multifunctional modified polyethylene glycol based crosslinking agent |
CA3175344A1 (en) * | 2020-03-20 | 2021-09-23 | Bard Peripheral Vascular, Inc. | Reactive hydrogel forming formulations and related methods |
US11739166B2 (en) | 2020-07-02 | 2023-08-29 | Davol Inc. | Reactive polysaccharide-based hemostatic agent |
CA3177039A1 (en) | 2020-12-28 | 2022-07-07 | Davol Inc. | Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL47468A (en) | 1975-06-12 | 1979-05-31 | Rehovot Res Prod | Process for the cross-linking of proteins using water soluble cross-linking agents |
GB2042888B (en) | 1979-03-05 | 1983-09-28 | Teijin Ltd | Preparation for administration to the mucosa of the oral or nasal cavity |
US4349530A (en) * | 1980-12-11 | 1982-09-14 | The Ohio State University | Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal |
US4839345A (en) * | 1985-03-09 | 1989-06-13 | Nippon Oil And Fats Co., Ltd. | Hydrated adhesive gel and method for preparing the same |
US4919939A (en) | 1986-04-29 | 1990-04-24 | Pharmetrix Corporation | Periodontal disease treatment system |
US4897268A (en) | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
US4898734A (en) | 1988-02-29 | 1990-02-06 | Massachusetts Institute Of Technology | Polymer composite for controlled release or membrane formation |
US4976968A (en) | 1989-02-24 | 1990-12-11 | Clinical Technologies Associates, Inc. | Anhydrous delivery systems for pharmacological agents |
ES2247656T3 (es) | 1989-04-19 | 2006-03-01 | Enzon, Inc. | Un proceso para formar un polipeptido modificado que comprende un polipeptido y un oxido de polialquileno. |
DE4120760A1 (de) * | 1991-06-24 | 1993-03-04 | 3 M Medica Gmbh | Traegersysteme fuer arzneimittel |
US5302397A (en) | 1991-11-19 | 1994-04-12 | Amsden Brian G | Polymer-based drug delivery system |
WO1993015722A1 (en) | 1992-02-07 | 1993-08-19 | Syntex (Usa) Inc. | Controlled delivery of pharmaceuticals from preformed porous microparticles |
GB9206509D0 (en) | 1992-03-25 | 1992-05-06 | Jevco Ltd | Heteromorphic sponges containing active agents |
US5514379A (en) * | 1992-08-07 | 1996-05-07 | The General Hospital Corporation | Hydrogel compositions and methods of use |
US5340614A (en) | 1993-02-11 | 1994-08-23 | Minnesota Mining And Manufacturing Company | Methods of polymer impregnation |
US5362478A (en) * | 1993-03-26 | 1994-11-08 | Vivorx Pharmaceuticals, Inc. | Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell |
EP0705298B1 (en) * | 1993-12-01 | 2002-03-27 | Bioartificial Gel Technologies Inc. | Albumin based hydrogel |
PT754032E (pt) | 1994-04-08 | 2002-05-31 | Atrix Lab Inc | Composicoes liquidas para difusao |
US5583114A (en) | 1994-07-27 | 1996-12-10 | Minnesota Mining And Manufacturing Company | Adhesive sealant composition |
AU4711599A (en) * | 1998-06-23 | 2000-01-10 | Surgical Sealants, Incorporated | Carbodiimide cross-linked albumin for bioadhesives, surgical sealants and implantable devices |
KR20020081687A (ko) * | 2000-02-17 | 2002-10-30 | 쓰리엠 이노베이티브 프로퍼티즈 캄파니 | 예비성형된 생분해성 중합체 조성물을 사용하는 전달시스템과 방법들 |
-
2001
- 2001-02-16 KR KR1020027010681A patent/KR20020081687A/ko active Search and Examination
- 2001-02-16 CN CNB018050662A patent/CN1211076C/zh not_active Expired - Lifetime
- 2001-02-16 AU AU3838401A patent/AU3838401A/xx active Pending
- 2001-02-16 BR BR0108471-2A patent/BR0108471A/pt not_active Application Discontinuation
- 2001-02-16 ES ES01910817T patent/ES2706000T3/es not_active Expired - Lifetime
- 2001-02-16 WO PCT/US2001/005020 patent/WO2001060335A2/en active Application Filing
- 2001-02-16 JP JP2001559433A patent/JP5154726B2/ja not_active Expired - Fee Related
- 2001-02-16 MX MXPA02007938A patent/MXPA02007938A/es active IP Right Grant
- 2001-02-16 CA CA2398668A patent/CA2398668C/en not_active Expired - Lifetime
- 2001-02-16 US US09/784,934 patent/US6576263B2/en not_active Expired - Lifetime
- 2001-02-16 AU AU2001238384A patent/AU2001238384B2/en not_active Expired
- 2001-02-16 EP EP01910817.4A patent/EP1257257B1/en not_active Expired - Lifetime
-
2012
- 2012-08-17 JP JP2012181148A patent/JP5781994B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20020009492A1 (en) | 2002-01-24 |
ES2706000T3 (es) | 2019-03-27 |
CA2398668A1 (en) | 2001-08-23 |
WO2001060335A2 (en) | 2001-08-23 |
CN1400893A (zh) | 2003-03-05 |
JP5781994B2 (ja) | 2015-09-24 |
JP5154726B2 (ja) | 2013-02-27 |
EP1257257A2 (en) | 2002-11-20 |
JP2003522780A (ja) | 2003-07-29 |
AU3838401A (en) | 2001-08-27 |
KR20020081687A (ko) | 2002-10-30 |
JP2013010774A (ja) | 2013-01-17 |
AU2001238384B2 (en) | 2006-05-18 |
US6576263B2 (en) | 2003-06-10 |
EP1257257B1 (en) | 2018-10-31 |
CN1211076C (zh) | 2005-07-20 |
WO2001060335A3 (en) | 2002-04-18 |
CA2398668C (en) | 2010-06-15 |
MXPA02007938A (es) | 2003-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0108471A (pt) | Objeto pré-formado para liberar um agente ativo a um paciente, e, processos de formação de um objeto pré-formado para liberar um agente e de liberação de um agente ativo a um paciente | |
BR0208636A (pt) | Agente terapêutico para doenças de artrìtides crÈnicas de doenças relacionadas com infncia | |
BR0213358A (pt) | Uso de flibanserina | |
DOP2002000429A (es) | Imidazotriazinas | |
ES2109832T3 (es) | Composicion dermatologica o farmaceutica, procedimiento de preparacion y utilizacion | |
BR0112054A (pt) | Composição formadora de micelas, e métodos para a administração e a proteção de um agente terapêutico | |
AU2001236744A1 (en) | Delivery system for topical skin care agents | |
SE0100901D0 (sv) | New composition | |
EE200300212A (et) | Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks | |
BR9804500B1 (pt) | derivado de amida, referida composição farmacêutica e agente terapêutico. | |
HN2001000281A (es) | Nuevas imidazotriazinonas sustituidas | |
AR030829A1 (es) | Una formulacion de vacuna, procedimiento para la produccion de la misma, uso de dicha preparacion y un estuche para su administracion via intranasal | |
BR0107667A (pt) | Composto de linezolida em forma de cristal que e farmaceuticamente útil como agente antibacteriano e método de preparação do mesmo | |
AR031401A1 (es) | Adhesivo propicio para la piel y vendaje para heridas revestido con el mismo | |
DE50105771D1 (de) | Ibuprofen-wirkstoffzubereitung | |
EE05474B1 (et) | Antikehade kasutamine farmatseutilise kompositsiooni valmistamiseks, mis on ette nhtud vhivastaseks vaktsineerimiseks | |
WO2003005880A3 (en) | Replikin peptides and uses thereof | |
BR0207066A (pt) | Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles | |
BR0210632A (pt) | Tratamento de doença parasìtica | |
AU2381402A (en) | Small acid-soluble spore protein and uses thereof | |
BR0115983A (pt) | Uso de sarp-1 para o tratamento e/ou prevenção de escleroderma | |
ES2180750T3 (es) | Conjugado de un principio activo, un polieter y, en caso dado, una proteina nativa no considerada como exogena. | |
ES2152315T3 (es) | Xamoneline tartrato. | |
ES2195405T3 (es) | Derivado de tiadiazol carboxamida, agente fitosanitario, y utilizacion. | |
DE60214154D1 (de) | Pharmazeutisches freigabekonstrukt zur magenretention |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DA INT.CL: A61K 9/00 Ipc: A61K 47/42 (2010.01), A61K 9/16 (2010.01), A61K 9/ |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13, 24 E 25 DA LPI |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |